IMAX CORP (IMAX) Fundamental Analysis & Valuation

NYSE:IMAX • CA45245E1097

Current stock price

36.765 USD
-0.17 (-0.47%)
Last:

This IMAX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. IMAX Profitability Analysis

1.1 Basic Checks

  • In the past year IMAX was profitable.
  • IMAX had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: IMAX reported negative net income in multiple years.
  • In the past 5 years IMAX always reported a positive cash flow from operatings.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.90%, IMAX belongs to the top of the industry, outperforming 83.54% of the companies in the same industry.
  • IMAX's Return On Equity of 10.32% is amongst the best of the industry. IMAX outperforms 81.01% of its industry peers.
  • IMAX has a Return On Invested Capital of 10.24%. This is amongst the best in the industry. IMAX outperforms 91.14% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for IMAX is significantly below the industry average of 159.10%.
  • The 3 year average ROIC (7.50%) for IMAX is below the current ROIC(10.24%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.9%
ROE 10.32%
ROIC 10.24%
ROA(3y)3.38%
ROA(5y)0.97%
ROE(3y)9.43%
ROE(5y)2.68%
ROIC(3y)7.5%
ROIC(5y)4.8%
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.50%, IMAX is in the better half of the industry, outperforming 79.75% of the companies in the same industry.
  • IMAX has a Operating Margin of 23.04%. This is amongst the best in the industry. IMAX outperforms 92.41% of its industry peers.
  • IMAX's Operating Margin has improved in the last couple of years.
  • IMAX has a better Gross Margin (60.02%) than 64.56% of its industry peers.
  • In the last couple of years the Gross Margin of IMAX has grown nicely.
Industry RankSector Rank
OM 23.04%
PM (TTM) 8.5%
GM 60.02%
OM growth 3Y103.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.9%
GM growth 5Y30.77%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. IMAX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IMAX is still creating some value.
  • IMAX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for IMAX has been reduced compared to 5 years ago.
  • Compared to 1 year ago, IMAX has an improved debt to assets ratio.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • IMAX has an Altman-Z score of 2.76. This is not the best score and indicates that IMAX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • IMAX has a Altman-Z score of 2.76. This is in the better half of the industry: IMAX outperforms 77.22% of its industry peers.
  • The Debt to FCF ratio of IMAX is 2.45, which is a good value as it means it would take IMAX, 2.45 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 2.45, IMAX belongs to the best of the industry, outperforming 81.01% of the companies in the same industry.
  • IMAX has a Debt/Equity ratio of 0.71. This is a neutral value indicating IMAX is somewhat dependend on debt financing.
  • IMAX has a Debt to Equity ratio (0.71) which is comparable to the rest of the industry.
  • Although IMAX's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 2.45
Altman-Z 2.76
ROIC/WACC1.35
WACC7.59%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 1.80 indicates that IMAX should not have too much problems paying its short term obligations.
  • IMAX's Current ratio of 1.80 is fine compared to the rest of the industry. IMAX outperforms 74.68% of its industry peers.
  • IMAX has a Quick Ratio of 1.60. This is a normal value and indicates that IMAX is financially healthy and should not expect problems in meeting its short term obligations.
  • IMAX's Quick ratio of 1.60 is fine compared to the rest of the industry. IMAX outperforms 72.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.6
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. IMAX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 51.58% over the past year.
  • The Earnings Per Share has been growing by 174.00% on average over the past years. This is a very strong growth
  • IMAX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.47%.
  • IMAX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.53% yearly.
EPS 1Y (TTM)51.58%
EPS 3Y174%
EPS 5YN/A
EPS Q2Q%114.81%
Revenue 1Y (TTM)16.47%
Revenue growth 3Y10.89%
Revenue growth 5Y24.53%
Sales Q2Q%35.11%

3.2 Future

  • IMAX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.86% yearly.
  • IMAX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.47% yearly.
EPS Next Y19.65%
EPS Next 2Y17.92%
EPS Next 3Y16.32%
EPS Next 5Y17.86%
Revenue Next Year8.83%
Revenue Next 2Y8.15%
Revenue Next 3Y7.47%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. IMAX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 25.53, IMAX can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of IMAX indicates a rather cheap valuation: IMAX is cheaper than 84.81% of the companies listed in the same industry.
  • IMAX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.18, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 21.34, which indicates a rather expensive current valuation of IMAX.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of IMAX indicates a rather cheap valuation: IMAX is cheaper than 82.28% of the companies listed in the same industry.
  • IMAX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 37.96.
Industry RankSector Rank
PE 25.53
Fwd PE 21.34
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IMAX is valued a bit cheaper than 78.48% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, IMAX is valued cheaper than 84.81% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.48
EV/EBITDA 13.75
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • IMAX has a very decent profitability rating, which may justify a higher PE ratio.
  • IMAX's earnings are expected to grow with 16.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.3
PEG (5Y)N/A
EPS Next 2Y17.92%
EPS Next 3Y16.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IMAX Dividend Analysis

5.1 Amount

  • No dividends for IMAX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IMAX Fundamentals: All Metrics, Ratios and Statistics

IMAX CORP

NYSE:IMAX (4/14/2026, 2:43:34 PM)

36.765

-0.17 (-0.47%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-25
Earnings (Next)04-23
Inst Owners90.22%
Inst Owner Change0%
Ins Owners18.77%
Ins Owner Change-0.14%
Market Cap1.98B
Revenue(TTM)410.21M
Net Income(TTM)34.88M
Analysts82.22
Price Target46.36 (26.1%)
Short Float %13.62%
Short Ratio5.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.9%
Min EPS beat(2)20.72%
Max EPS beat(2)25.08%
EPS beat(4)4
Avg EPS beat(4)19.49%
Min EPS beat(4)11.91%
Max EPS beat(4)25.08%
EPS beat(8)7
Avg EPS beat(8)39.29%
EPS beat(12)11
Avg EPS beat(12)56.86%
EPS beat(16)11
Avg EPS beat(16)9.47%
Revenue beat(2)1
Avg Revenue beat(2)0.56%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)1.69%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-1.46%
Max Revenue beat(4)1.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.13%
Revenue beat(12)6
Avg Revenue beat(12)1.38%
Revenue beat(16)7
Avg Revenue beat(16)0.86%
PT rev (1m)2.53%
PT rev (3m)5.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.36%
EPS NY rev (1m)0%
EPS NY rev (3m)2.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.75%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.22%
Valuation
Industry RankSector Rank
PE 25.53
Fwd PE 21.34
P/S 4.84
P/FCF 17.48
P/OCF 15.62
P/B 5.87
P/tB 8.13
EV/EBITDA 13.75
EPS(TTM)1.44
EY3.92%
EPS(NY)1.72
Fwd EY4.69%
FCF(TTM)2.1
FCFY5.72%
OCF(TTM)2.35
OCFY6.4%
SpS7.6
BVpS6.26
TBVpS4.52
PEG (NY)1.3
PEG (5Y)N/A
Graham Number14.24
Profitability
Industry RankSector Rank
ROA 3.9%
ROE 10.32%
ROCE 12.91%
ROIC 10.24%
ROICexc 12.91%
ROICexgc 20.22%
OM 23.04%
PM (TTM) 8.5%
GM 60.02%
FCFM 27.69%
ROA(3y)3.38%
ROA(5y)0.97%
ROE(3y)9.43%
ROE(5y)2.68%
ROIC(3y)7.5%
ROIC(5y)4.8%
ROICexc(3y)9.01%
ROICexc(5y)5.78%
ROICexgc(3y)13.75%
ROICexgc(5y)8.74%
ROCE(3y)9.45%
ROCE(5y)6.05%
ROICexgc growth 3Y137.81%
ROICexgc growth 5YN/A
ROICexc growth 3Y126.07%
ROICexc growth 5YN/A
OM growth 3Y103.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.9%
GM growth 5Y30.77%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 2.45
Debt/EBITDA 1.56
Cap/Depr 22.57%
Cap/Sales 3.29%
Interest Coverage 19.38
Cash Conversion 82.36%
Profit Quality 325.66%
Current Ratio 1.8
Quick Ratio 1.6
Altman-Z 2.76
F-Score8
WACC7.59%
ROIC/WACC1.35
Cap/Depr(3y)24.91%
Cap/Depr(5y)22.45%
Cap/Sales(3y)4.01%
Cap/Sales(5y)3.86%
Profit Quality(3y)235.18%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.58%
EPS 3Y174%
EPS 5YN/A
EPS Q2Q%114.81%
EPS Next Y19.65%
EPS Next 2Y17.92%
EPS Next 3Y16.32%
EPS Next 5Y17.86%
Revenue 1Y (TTM)16.47%
Revenue growth 3Y10.89%
Revenue growth 5Y24.53%
Sales Q2Q%35.11%
Revenue Next Year8.83%
Revenue Next 2Y8.15%
Revenue Next 3Y7.47%
Revenue Next 5YN/A
EBIT growth 1Y97.55%
EBIT growth 3Y125.88%
EBIT growth 5YN/A
EBIT Next Year109.11%
EBIT Next 3Y36.37%
EBIT Next 5Y23.69%
FCF growth 1Y110.48%
FCF growth 3Y193.33%
FCF growth 5YN/A
OCF growth 1Y79.38%
OCF growth 3Y94.39%
OCF growth 5YN/A

IMAX CORP / IMAX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for IMAX CORP?

ChartMill assigns a fundamental rating of 6 / 10 to IMAX.


Can you provide the valuation status for IMAX CORP?

ChartMill assigns a valuation rating of 6 / 10 to IMAX CORP (IMAX). This can be considered as Fairly Valued.


How profitable is IMAX CORP (IMAX) stock?

IMAX CORP (IMAX) has a profitability rating of 7 / 10.


How financially healthy is IMAX CORP?

The financial health rating of IMAX CORP (IMAX) is 7 / 10.


Can you provide the expected EPS growth for IMAX stock?

The Earnings per Share (EPS) of IMAX CORP (IMAX) is expected to grow by 19.65% in the next year.